Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unresectable Gallbladder Cancer × camrelizumab × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Unresectable Gallbladder Cancer 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06423170 2024-05-21

A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting

GastrointestinalGenitourinary

Unresectable Gallbladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡